Cargando…
Role of Lipid Indices in the Assessment of Microvascular Risk in Type 2 Diabetic Retinopathy Patients
Introduction: Diabetic retinopathy (DR) remains the leading cause of blindness and visual impairment in diabetic patients worldwide. Lipid indices (LI) such as atherogenic coefficient (AC), atherogenic index of plasma (AIP), non-high-density lipoprotein cholesterol (non-HDL-C), and Castelli risk ind...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033511/ https://www.ncbi.nlm.nih.gov/pubmed/35481317 http://dx.doi.org/10.7759/cureus.23395 |
_version_ | 1784692907382407168 |
---|---|
author | Namitha, Devegowda Nusrath, Aliya Asha Rani, N. Dhananjaya, Shilpashree Y Lokanathan, Tejaswi H Kruthi, B.N. Vijay Kumar, A.G. |
author_facet | Namitha, Devegowda Nusrath, Aliya Asha Rani, N. Dhananjaya, Shilpashree Y Lokanathan, Tejaswi H Kruthi, B.N. Vijay Kumar, A.G. |
author_sort | Namitha, Devegowda |
collection | PubMed |
description | Introduction: Diabetic retinopathy (DR) remains the leading cause of blindness and visual impairment in diabetic patients worldwide. Lipid indices (LI) such as atherogenic coefficient (AC), atherogenic index of plasma (AIP), non-high-density lipoprotein cholesterol (non-HDL-C), and Castelli risk index (CRI) I and II may be associated with bio-physiological changes of DR even when traditional lipids are within normal limit. Hence, the present study was undertaken to evaluate the LI and examine the LI predictive role in assessing the microvascular risk in diabetes patients with and without retinopathy. Methodology: This case-control study was conducted for six months at a tertiary care hospital and included 90 subjects divided into three groups. Group I had 30 age and sex-matched healthy controls; group II and group III had 30 type 2 diabetes mellitus (T2DM) cases without DR and with DR, respectively. Plasma glucose and lipid profiles including apolipoprotein A-I (Apo A-I) and apolipoprotein B (Apo B) were measured in all subjects. LI such as AIP, AC, CRI-I, CRI-II, and non-HDL-C were calculated from the lipid profile values. ANOVA test was used to compare the means of three groups. Results: The mean age of the study participants was 51.44 ± 11.72, 53.95 ± 12.43, and 57.16 ± 7.96 years for groups I, II, and III, respectively. Triacylglycerol (TG) showed positive correlation with all LI, AIP (r = 0.768, p < 0.00001), AC (r = 0.363, p = 0.048), non-HDL-C (r = 0.372, p = 0.042), and CRI-I (r = 0.363, p = 0.048), except for CRI-II in group III. Low-density lipoprotein cholesterol (LDL-C) showed a statistically significant positive correlation with non-HDL-C and CRI-II in diabetic subjects with and without retinopathy. Conclusion: The study showed that LI were raised in diabetic patients with or without DR, suggesting the significant role of LI in assessing microvascular risk in T2DM, particularly when the lipid profile values seem to be normal or not disturbed markedly. |
format | Online Article Text |
id | pubmed-9033511 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-90335112022-04-26 Role of Lipid Indices in the Assessment of Microvascular Risk in Type 2 Diabetic Retinopathy Patients Namitha, Devegowda Nusrath, Aliya Asha Rani, N. Dhananjaya, Shilpashree Y Lokanathan, Tejaswi H Kruthi, B.N. Vijay Kumar, A.G. Cureus Endocrinology/Diabetes/Metabolism Introduction: Diabetic retinopathy (DR) remains the leading cause of blindness and visual impairment in diabetic patients worldwide. Lipid indices (LI) such as atherogenic coefficient (AC), atherogenic index of plasma (AIP), non-high-density lipoprotein cholesterol (non-HDL-C), and Castelli risk index (CRI) I and II may be associated with bio-physiological changes of DR even when traditional lipids are within normal limit. Hence, the present study was undertaken to evaluate the LI and examine the LI predictive role in assessing the microvascular risk in diabetes patients with and without retinopathy. Methodology: This case-control study was conducted for six months at a tertiary care hospital and included 90 subjects divided into three groups. Group I had 30 age and sex-matched healthy controls; group II and group III had 30 type 2 diabetes mellitus (T2DM) cases without DR and with DR, respectively. Plasma glucose and lipid profiles including apolipoprotein A-I (Apo A-I) and apolipoprotein B (Apo B) were measured in all subjects. LI such as AIP, AC, CRI-I, CRI-II, and non-HDL-C were calculated from the lipid profile values. ANOVA test was used to compare the means of three groups. Results: The mean age of the study participants was 51.44 ± 11.72, 53.95 ± 12.43, and 57.16 ± 7.96 years for groups I, II, and III, respectively. Triacylglycerol (TG) showed positive correlation with all LI, AIP (r = 0.768, p < 0.00001), AC (r = 0.363, p = 0.048), non-HDL-C (r = 0.372, p = 0.042), and CRI-I (r = 0.363, p = 0.048), except for CRI-II in group III. Low-density lipoprotein cholesterol (LDL-C) showed a statistically significant positive correlation with non-HDL-C and CRI-II in diabetic subjects with and without retinopathy. Conclusion: The study showed that LI were raised in diabetic patients with or without DR, suggesting the significant role of LI in assessing microvascular risk in T2DM, particularly when the lipid profile values seem to be normal or not disturbed markedly. Cureus 2022-03-22 /pmc/articles/PMC9033511/ /pubmed/35481317 http://dx.doi.org/10.7759/cureus.23395 Text en Copyright © 2022, Namitha et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Endocrinology/Diabetes/Metabolism Namitha, Devegowda Nusrath, Aliya Asha Rani, N. Dhananjaya, Shilpashree Y Lokanathan, Tejaswi H Kruthi, B.N. Vijay Kumar, A.G. Role of Lipid Indices in the Assessment of Microvascular Risk in Type 2 Diabetic Retinopathy Patients |
title | Role of Lipid Indices in the Assessment of Microvascular Risk in Type 2 Diabetic Retinopathy Patients |
title_full | Role of Lipid Indices in the Assessment of Microvascular Risk in Type 2 Diabetic Retinopathy Patients |
title_fullStr | Role of Lipid Indices in the Assessment of Microvascular Risk in Type 2 Diabetic Retinopathy Patients |
title_full_unstemmed | Role of Lipid Indices in the Assessment of Microvascular Risk in Type 2 Diabetic Retinopathy Patients |
title_short | Role of Lipid Indices in the Assessment of Microvascular Risk in Type 2 Diabetic Retinopathy Patients |
title_sort | role of lipid indices in the assessment of microvascular risk in type 2 diabetic retinopathy patients |
topic | Endocrinology/Diabetes/Metabolism |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9033511/ https://www.ncbi.nlm.nih.gov/pubmed/35481317 http://dx.doi.org/10.7759/cureus.23395 |
work_keys_str_mv | AT namithadevegowda roleoflipidindicesintheassessmentofmicrovascularriskintype2diabeticretinopathypatients AT nusrathaliya roleoflipidindicesintheassessmentofmicrovascularriskintype2diabeticretinopathypatients AT asharanin roleoflipidindicesintheassessmentofmicrovascularriskintype2diabeticretinopathypatients AT dhananjayashilpashreey roleoflipidindicesintheassessmentofmicrovascularriskintype2diabeticretinopathypatients AT lokanathantejaswih roleoflipidindicesintheassessmentofmicrovascularriskintype2diabeticretinopathypatients AT kruthibn roleoflipidindicesintheassessmentofmicrovascularriskintype2diabeticretinopathypatients AT vijaykumarag roleoflipidindicesintheassessmentofmicrovascularriskintype2diabeticretinopathypatients |